Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom.
Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, The University of Edinburgh, Edinburgh, United Kingdom.
Front Immunol. 2022 Apr 11;13:887380. doi: 10.3389/fimmu.2022.887380. eCollection 2022.
The presence of functionally efficient cytotoxic T lymphocytes (CTL) in the Tumour nest is crucial in mediating a successful immune response to cancer. The detection and elimination of cancer cells by CTL can be impaired by cancer-mediated immune evasion. In recent years, it has become increasingly clear that not only neoplastic cells themselves, but also cells of the tumour microenvironment (TME) exert immunosuppressive functions and thereby play an integral part in the immune escape of cancer. The most abundant stromal cells of the TME, cancer associated fibroblasts (CAFs), promote tumour progression multiple pathways and play a role in dampening the immune response to cancer. Recent research indicates that T cells react to CAF signalling and establish bidirectional crosstalk that plays a significant role in the tumour immune response. This review discusses the various mechanisms by which the CAF/T cell crosstalk may impede anti-cancer immunity.
肿瘤巢中功能有效的细胞毒性 T 淋巴细胞 (CTL) 的存在对于介导对癌症的成功免疫反应至关重要。CTL 通过检测和消除癌细胞,但会受到癌症介导的免疫逃逸的影响。近年来,越来越清楚的是,不仅肿瘤细胞本身,而且肿瘤微环境 (TME) 的细胞也发挥免疫抑制功能,从而成为癌症免疫逃逸的一个组成部分。TME 中最丰富的基质细胞,即癌相关成纤维细胞 (CAF),通过多种途径促进肿瘤进展,并在抑制对癌症的免疫反应中发挥作用。最近的研究表明,T 细胞对 CAF 信号作出反应并建立双向串扰,这在肿瘤免疫反应中起着重要作用。本综述讨论了 CAF/T 细胞串扰可能阻碍抗癌免疫的各种机制。
Front Endocrinol (Lausanne). 2022
Semin Immunopathol. 2023-3
Curr Opin Immunol. 2024-2
Int Immunopharmacol. 2023-9
Naunyn Schmiedebergs Arch Pharmacol. 2025-3-10
Cancer Immunol Immunother. 2025-3-1
J Cancer Res Clin Oncol. 2024-10-16